Table 1 Demographic and Treatment Data
From: Genetic commonality of macrolide-resistant group A beta hemolytic streptococcus pharyngeal strains
Site A | Site B | |
|---|---|---|
Median/Mean age | 6 yrs/7.5 yrs | 6 yrs/7.5 yrs |
Male | 104/200 (52%) | 105/200 (53%) |
Caucasian | 61/200 (30%) | 161/200 (80%) |
Medicaid | 131/200 (65%) | 108/200 (52%) |
Penicillin/amoxicillin | 178/200 (91%) | 179/200 (90%) |
Oral cephalosporin | 8/200 (4%) | 20/200 (10%) |
Other/none | 14/200 (7%) | 1/200 (0.5%) |